STEK (Stemtech) Total Assets : $3.64 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Stemtech Total Assets?

Stemtech's Total Assets for the quarter that ended in Sep. 2024 was $3.64 Mil.

During the past 12 months, Stemtech's average Total Assets Growth Rate was -11.70% per year. During the past 3 years, the average Total Assets Growth Rate was -9.90% per year.

During the past 4 years, Stemtech's highest 3-Year average Total Assets Growth Rate was -9.90%. The lowest was -9.90%. And the median was -9.90%.

Total Assets is connected with ROA %. Stemtech's annualized ROA % for the quarter that ended in Sep. 2024 was -127.71%. Total Assets is also linked to Revenue through Asset Turnover. Stemtech's Asset Turnover for the quarter that ended in Sep. 2024 was 0.28.

Stemtech Total Assets Historical Data

The historical data trend for Stemtech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stemtech Total Assets Chart

Stemtech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Assets

5.01

5.72

4.27

3.68

Stemtech Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial												4.15	3.68	3.61	3.69	3.64

Stemtech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Stemtech's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	-2.779	+	6.462
	=	3.68

Stemtech's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2024 )	+	Total Liabilities (Q: Sep. 2024 )
	=	-5.951	+	9.59
	=	3.64

Stemtech (OTCPK:STEK) Total Assets Explanation

Total Assets is connected with ROA %.

Stemtech's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %	=	Net Income (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	-4.68	/	( (3.69	+	3.639)	/ 2 )
	=	-4.68	/	3.6645
	=	-127.71 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Stemtech's Asset Turnover for the quarter that ended in Sep. 2024 is

	Asset Turnover
=	Revenue (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
=	1.032	/	( (3.69	+	3.639)	/ 2 )
=	1.032	/	3.6645
=	0.28

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Stemtech Total Assets Related Terms

Thank you for viewing the detailed overview of Stemtech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Stemtech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stemtech Corp (OTCPK:STEK) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

4851 Tamiami Trail North, Suite 200, Naples, FL, USA, 34103

Website

https://www.stemtech.com

Stemtech Corp is a nutraceutical company. Its products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where perform their daily function of renewal for optimal health. It markets its products under the following brands: RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze. Geographically, it derives a majority of its revenue from the Americas.

Executives

Charles Stuart Arnold	director	520 BRICKELL KEY DR #1607, MIAMI FL 33131
Mindshare Holdings, Inc.	10 percent owner	419 BOSTWICK LANE, GAITHERSBURG MD 20878
Darryl V Green	director	300 SIXTH AVENUE, PITTSBURGH PA 15222
John William Meyer	director	10370 USA TODAY WAY, MIRAMAR FL 33025
Benjamin Nathaniel Kaplan	director	13005 CORONOADO LANE, NORTH MIAMI FL 33181